1. Home
  2. WEN vs IMCR Comparison

WEN vs IMCR Comparison

Compare WEN & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$6.87

Market Cap

1.4B

ML Signal

HOLD

IMCR

Immunocore Holdings plc

HOLD

Current Price

$28.59

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEN
IMCR
Founded
1969
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2000
2016

Fundamental Metrics

Financial Performance
Metric
WEN
IMCR
Price
$6.87
$28.59
Analyst Decision
Hold
Buy
Analyst Count
22
10
Target Price
$8.84
$66.33
AVG Volume (30 Days)
8.3M
432.7K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
8.28%
N/A
EPS Growth
N/A
30.39
EPS
0.12
0.25
Revenue
$2,176,891,000.00
$249,428,000.00
Revenue This Year
$2.26
$14.57
Revenue Next Year
$0.94
$8.21
P/E Ratio
$57.83
$114.16
Revenue Growth
N/A
43.05
52 Week Low
$6.37
$27.56
52 Week High
$12.51
$40.71

Technical Indicators

Market Signals
Indicator
WEN
IMCR
Relative Strength Index (RSI) 44.84 49.22
Support Level $6.62 $27.66
Resistance Level $7.28 $31.56
Average True Range (ATR) 0.31 1.21
MACD -0.02 0.04
Stochastic Oscillator 25.56 51.86

Price Performance

Historical Comparison
WEN
IMCR

About WEN Wendy's Company (The)

The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: